Apria Healthcare Group Competitors and Similar CompaniesClear all

Apria Healthcare Group's competitors and similar companies include Tandem Diabetes Care, Acelity, Penumbra and Endologix.
Apria Healthcare Group
Apria Healthcare Group
Apria Healthcare Group is a company that provides home respiratory services and medical equipment.
Tandem Diabetes Care
Tandem Diabetes Care
Tandem Diabetes Care is a medical device company that engages in the design, development, and commercialization of products for people with insulin-dependent diabetes.
Acelity
Acelity
Acelity is a medical device company offering wound therapeutics products.
Penumbra
Penumbra
Penumbra is a healthcare company that designs, develops, and manufactures medical devices.
Endologix
Endologix
Endologix is a medical device company that provides therapies for the treatment of vascular disease.
Founding Date
Founding Date
N/A
Founding Date
2006
Founding Date
1976
Founding Date
2004
Founding Date
1992
Type
Type
Subsidiary
Type
Public
Type
Subsidiary
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Indianapolis, US HQ
Lake Forest, US
Locations
San Diego, US HQ
Markham, CA
Schiphol, NL
Locations
San Antonio, US HQ
Lane Cove West, AU
Wien, AT
Wien, AT
Mississauga, CA
see more
Locations
Alameda, US HQ
Darlinghurst, AU
São Paulo, BR
Berlin, DE
Berlin, DE
Rivoli, IT
Alameda, US
see more
Locations
Irvine, US HQ
's Hertogenbosch, NL
Milpitas, US
Santa Rosa, US
Employees
Employees
5,666
Employees
2,65010% increase
Employees
2,106
Employees
4,2008% increase
Employees
4351% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
2.2 b
Valuation ($)
N/A
Valuation ($)
8.1 b
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$1.1b (FY, 2021)
Revenue (est.)
$1b (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
$1.4b (FY, 2025)
Revenue (est.)
$143.4m (FY, 2019)
Cost of goods
Cost of goods
$341.3m (FY, 2021)
Cost of goods
$468.7m (FY, 2025)
Cost of goods
N/A
Cost of goods
$461.2m (FY, 2025)
Cost of goods
$52.3m (FY, 2019)
Gross profit
Gross profit
$804m (FY, 2021)
Gross profit
$546m (FY, 2025)
Gross profit
N/A
Gross profit
$942.4m (FY, 2025)
Gross profit
$91.1m (FY, 2019)
Net income
Net income
$64.9m (FY, 2021)
Net income
($204.7m) (FY, 2025)
Net income
N/A
Net income
$177.7m (FY, 2025)
Net income
($64.8m) (FY, 2019)

Operating

Patents Pending
Patents Pending
N/A
Patents Pending
83 (FY, 2021)
Patents Pending
N/A
Patents Pending
68 (Dec, 2023)
Patents Pending
N/A
Trademarks (US)
Trademarks (US)
N/A
Trademarks (US)
N/A
Trademarks (US)
N/A
Trademarks (US)
43 (Dec, 2023)
Trademarks (US)
16 (Jan, 2024)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 401.5m
Total funding raised
N/A
Total funding raised
$ 121.2k
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Tandem Diabetes Care
HQ
San Diego, US
Employees
2,650↑ 10% increase

Tandem Diabetes Care is a medical device company that engages in the design, development, and commercialization of products for people with insulin-dependent diabetes.

View company
Acelity
HQ
San Antonio, US

Acelity is a medical device company offering wound therapeutics products.

View company
Penumbra
HQ
Alameda, US
Employees
4,200↑ 8% increase

Penumbra is a healthcare company that designs, develops, and manufactures medical devices.

View company
Endologix
HQ
Irvine, US

Endologix is a medical device company that provides therapies for the treatment of vascular disease.

View company